Predictive role of the three-month CD4 cell count in the long-term clinical outcome of the first HAART regimen

Author:

d’Arminio Monforte A,Adorni F,Meroni L,Bini T,Testa L,Chiesa E,Melzi S,Rusconi S,Sollima S,Galli M,Moroni M

Publisher

Elsevier BV

Subject

Pharmacology,General Medicine

Reference19 articles.

1. Randomized placebo-controlled trial of ritonavir in advanced HIV-1 disease;Cameron;Lancet,1998

2. A controlled trial of two nucleoside analogues plus indinavir in persons with human immunodeficiency virus infection and CD4+ cell counts of 200 per cubic millimeter or less;Hammer;N Engl J M,1997

3. Clumeck N, for the Saquinavir International Phase III Trial (SV 14604) Group. Clinical benefit of Saquinavir (SQV) plus Zalcitabine (ddC) plus Zidovudine (ZDV) in untreated/minimally treated HIV-infected patients [abstract]. Interscience Conference on Antimicrobial Agents and Chemotherapy, 1997; Toronto, Canada

4. Declining morbidity and mortality among patients with advanced human immunodeficiency virus syndrome;Palella;N Engl J M,1998

5. Impact of protease inhibitors on AIDS-defining events and hospitalizations in 10 French AIDS reference centres. Federation National des Centres de Lutte contre le SIDA;Mouton;AIDS,1997

Cited by 4 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3